Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
78.60    1.60 (2.08%)
Bid:
76.20
Ask:
78.80
Spread: 2.60 (3.412%)
Market Cap: £191.16m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Result of AGM

24 Sep 2025 17:15

RNS Number : 7005A
Accsys Technologies PLC
24 September 2025
Β 

AIM: AXS

Euronext Amsterdam: AXS

Β 

Β 

24 September 2025

Accsys Technologies PLC

("Accsys", the "Group" or "the Company")

Β 

Results of AGM

Accsys, the world's leading supplier of premium, high performance and sustainable wood building materials, today confirms that all the resolutions put to the Annual General Meeting ("AGM") held on Wednesday 24 September 2025 were duly passed. All resolutions were decided on a poll. Resolutions 1 to 11 were passed as ordinary resolutions and resolutions 12 to 15 were passed as special resolutions. The voting results are set out below.

Resolution

For

Against

Β of issued share capital voted

Votes withheld

Number

%

Number

%

%

Number

Ordinary Resolutions

1: To receive the audited financial statements of the Company for the financial year ended 31 March 2025.

125,946,210

99.97

39,337

0.03

51.92

15,109

2: To approve the Directors' Remuneration Report (excluding the Remuneration Policy) for the financial year ended 31 March 2025.

125,510,764

99.62

479,837

0.38

51.92

10,055

3: To re-elect Trudy Schoolenberg as a director.

125,824,802

99.87

163,990

0.13

51.92

11,864

4. To re-elect Louis Eperjesi as a director.

125,793,475

99.85

190,317

0.15

51.92

16,864

5: To re-elect Roland Waibel as a director.

125,793,475

99.85

190,317

0.15

51.92

16,864

6: To re-elect Edwin Bouwman as a director.

125,733,245

99.80

250,547

0.20

51.92

16,864

7: To re-elect Jelena Arsic van Os as a director.

125,814,549

99.86

174,243

0.14

51.92

11,864

8: To elect Sameet Vohra as a director.

125,509,923

99.62

474,772

0.38

51.92

15,961

9: To re-appoint PricewaterhouseCoopers LLP as auditors.

125,904,560

99.94

78,189

0.06

51.92

17,907

10: To authorise the directors to determine the remuneration of the auditor.

125,577,815

99.90

123,907

0.10

51.92

298,934

11: To authorise the directors to allot shares.

125,458,153

99.58

530,766

0.42

51.92

11,737

Special Resolutions

12: To authorise the Directors to disapply statutory pre-emption rights in respect of 10% of the Company's issued share capital.

125,441,250

99.57

546,090

0.43

51.92

13,316

13: To authorise the Directors to disapply pre-emption rights for purposes of acquisitions or capital investments over an additional 10% of the Company's issued share capital.

125,477,748

99.59

512,592

0.41

51.92

10,316

14: To authorise the Company to purchase own shares.

125,804,525

99.85

187,394

0.15

51.92

8,737

15: To authorise a general meeting of the Company (other than an annual general meeting) to be called on not less than 14 clear days' notice

125,909,685

99.94

78,136

0.06

51.92

12,835

Β 

1. Any proxy arrangement which gave discretion to the Chairman has been included in the "for" totals.

2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.

3. The issued share capital ("ISC") at 6:00 p.m. on 22 September 2025 was 242,694,212 Ordinary shares of €0.05 each with no shares held in treasury.

Enquiries:

Accsys Investor Relations ir@accsysplc.com

Β 

Panmure Liberum (London) - NOMAD and Broker

Nicholas How (NOMAD), Will King +44 (0) 20 3100 2000

Β 

ABN Amro (Amsterdam) - Broker

Richard van Etten, Dennis van Helmond +31 (0) 20 344 2000

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RAGPKQBDABKDDCB
Date   Source Headline
16th Jun 20267:00 amRNSPreliminary results for the year end 31 March 2026
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSTotal Voting Rights
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.